Pricing Log in Create free account
Friday 6 November 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.

Revenue
+1.71%
EPS
−4.35%
Free cash flow
+54.9%
Total debt
−7.28%

Quarter to September 2026, against a year earlier

21.25 0.19 +0.90%
Market cap
$67.7B
P/E
32.0×
Fwd P/E
—
Dividend yield
1.45%
F-score
4/9
Altman Z
1.03
Beneish M
−2.65
Dividend safety
25/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Takeda Pharmaceutical Co. (TAK) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Takeda Pharmaceutical Co. (TAK) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 0.8× (June 2024) to 2.6× (January 2018); the current reading is higher than 63% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 1.8× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 1.2× 22.42%
FY2025 1.0× 11.82%
FY2024 0.9× (21.65%)
FY2023 1.1× 22.88%
FY2022 0.9× (24.48%)
FY2021 1.2× 7.84%
FY2020 1.1× (38.27%)
FY2019 1.8× (12.84%)
FY2018 2.0× (4.98%)
FY2017 2.1× 8.60%

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.1× 4.16%
Jun 2025 1.0× 24.96%
Jun 2024 0.8× (4.11%)
Mar 2024 0.9× (13.16%)
25 more quarters

Against its own ten years

Low 0.8× High 2.6×
Ten-year median 1.2×
Current reading's percentile 68

P/B ratio against peers

Company P/B ratio
TAK Takeda Pharmaceutical Co. 1.4×
VTRS Viatris Inc. compare 1.6×
ELAN Elanco Animal Health Incorporated compare 1.8×
HLN Haleon PLC Sponsored ADR compare 1.9×
RDY Dr. Reddy's Laboratories Ltd compare 3.0×
UTHR United Therapeutics Corporation compare 3.8×
NBIX Neurocrine Biosciences, Inc. compare 4.2×
TEVA Teva Pharmaceutical Industries Ltd. compare 6.1×
ZTS Zoetis Inc. compare 10.8×
Drug Manufacturers Specialty & Generic industry median 1.8×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on TAK